INDOCO REMEDIES Announces Quarterly Results (1QFY22); Net Profit Up 132.7%
Mon, 16 Aug

INDOCO REMEDIES has announced its results for the quarter ended June 2021. Here is a detailed performance review of the same:

INDOCO REMEDIES Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-20*
3
Mar-21*
3
Jun-21*
QoQ ChangeYoY Change
Net SalesRs m2,7593,0513,86826.7%40.2%
Other incomeRs m3209-56.6%230.8%
TurnoverRs m2,7613,0713,87626.2%40.4%
ExpensesRs m2,2722,5042,99919.7%32.0%
Gross profitRs m48754786958.8%78.6%
DepreciationRs m19118622219.8%16.2%
InterestRs m584642-7.6%-26.3%
Profit before taxRs m24033661382.6%155.1%
TaxRs m7086216152.7%209.4%
Profit after taxRs m17025039758.6%132.7%
Gross profit margin%17.617.922.5
Effective tax rate%29.125.535.3
Net profit margin%6.28.110.2

* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster


Year-on-Year Performance:
Quarter-on-Quarter Performance:

To see how INDOCO REMEDIES has performed over the last eight quarters,please visit here.

Vote Now or Never: India's most trusted corporate. Click here.

INDOCO REMEDIES Share Price Performance

Over the last one year, INDOCO REMEDIES share price has moved up from Rs 247.3 to Rs 476.0, registering a Gain of Rs 228.7 or around 92.5%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 25,872.9 (down 0.0%). Over the last one year it has moved up from 19,114.4 to 25,872.9, a gain of 6,759 points (up 35.4%).

Overall, the S&P BSE SENSEX is up 45.0% over the year.

Current Valuations

At the current price of Rs 476.0, the price to earnings (P/E) ratio of INDOCO REMEDIES stands at 37.9 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 6.5 times.

  

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (3QFY20); Net Profit Up 74.9%

Jan 27, 2020 | Updated on Jan 27, 2020

For the quarter ended December 2019, INDOCO REMEDIES has posted a net profit of Rs 93 m (up 74.9% YoY). Sales on the other hand came in at Rs 3 bn (up 10.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (2QFY20); Net Profit Up 194.1%

Nov 5, 2019 | Updated on Nov 5, 2019

For the quarter ended September 2019, INDOCO REMEDIES has posted a net profit of Rs 73 m (up 194.1% YoY). Sales on the other hand came in at Rs 3 bn (up 23.9% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

More Views on News

Most Popular

Aug 3, 2021

These stocks are the best from a traders point of view.

Aug 6, 2021

In this video, I'll tell you about a simple hack to increase your profits from day trading.

Aug 4, 2021

These stocks are good buys even at all-time high levels.

Aug 9, 2021

Is the worst behind for ITC now?

Aug 6, 2021

Retail investors showed great response to recently concluded IPOs. Another four offers open next week. Which one will you apply?

More